Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study protocol: double-blind, randomized, prospective, placebo controlled parallel group phase II study to investigate the effect of glycerol phenylbutyrate (GPB) on neurofilament light chain (NfL) levels in patients with corticobasal syndrome (CBS).

Neurological research and practice·2026
Same author

Longitudinal clinical proteomics reveals pneumonia type-specific protein biomarkers and autoantibodies.

JCI insight·2026
Same author

Associations between COVID-19 Severity, Cognitive Impairment, and Quality of Life in Individuals in Need of Care: Results from the Multicentre Registry Study BaCoM.

Dementia and geriatric cognitive disorders extra·2026
Same author

Assessment of Commutability in Factor VIII Activity Testing Using Fresh Human Plasma Samples.

Thrombosis and haemostasis·2026
Same author

Deterioration Of Blood Lipids During Early Postoperative Remission Of Cushing's Syndrome: A Longitudinal Cohort Study.

The Journal of clinical endocrinology and metabolism·2026
Same author

Longitudinal clinical proteomics reveals pneumonia type-specific protein biomarkers and autoantibodies.

medRxiv : the preprint server for health sciences·2026

Related Experiment Videos

Risk factor management: antiatherogenic therapies.

Stephan Gielen1, Marcus Sandri, Gerhard Schuler

  • 1Department of Internal Medicine/Cardiology, University of Leipzig - Heart Center, Leipzig, Germany. stephan.gielen@medizin.uni-leipzig.de

European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology
|August 14, 2009
PubMed
Summary

Aggressively lowering LDL cholesterol to below 75 mg/dl and adopting a healthy lifestyle with exercise can halt and even reverse atherosclerosis progression. Implementing known risk factor modifications is crucial for reducing cardiovascular events.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Atherosclerosis Research
  • Preventative Medicine

Background:

  • Stable atherosclerosis management relies on guideline-oriented therapy.
  • Advances in interventional techniques complement, but do not replace, medical management.
  • Aggressive lipid lowering shows potential for atherosclerosis regression.

Purpose of the Study:

  • To review current strategies for managing stable atherosclerosis.
  • To emphasize the role of lipid-lowering therapy and lifestyle modifications.
  • To highlight the importance of achieving target risk factor values.

Main Methods:

  • Review of recent studies on lipid-lowering effects on atheroma volume.
  • Analysis of the impact of statins' pleiotropic effects on cardiovascular events.
  • Examination of lifestyle changes, including physical exercise, in disease management.

Main Results:

  • Achieving low-density lipoprotein (LDL) levels <75 mg/dl may induce atherosclerosis regression.
  • Statins reduce cardiovascular events through anti-inflammatory effects.
  • Lifestyle changes and exercise can halt disease progression and reduce symptoms/events.

Conclusions:

  • Optimal medical therapy, lifestyle changes, and interventions are complementary.
  • Risk factor modification significantly contributes to reduced cardiovascular mortality.
  • Implementing existing knowledge on risk factor control is paramount for patient outcomes.